Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Prepaid Assets: 2020-2024

Historic Prepaid Assets for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Dec 2024 value amounting to $19.7 million.

  • Arcutis Biotherapeutics' Prepaid Assets rose 10.35% to $20.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.3 million, marking a year-over-year increase of 10.35%. This contributed to the annual value of $19.7 million for FY2024, which is 5.09% up from last year.
  • As of FY2024, Arcutis Biotherapeutics' Prepaid Assets stood at $19.7 million, which was up 5.09% from $18.7 million recorded in FY2023.
  • Arcutis Biotherapeutics' Prepaid Assets' 5-year high stood at $19.7 million during FY2024, with a 5-year trough of $6.8 million in FY2020.
  • Moreover, its 3-year median value for Prepaid Assets was $18.7 million (2023), whereas its average is $16.3 million.
  • As far as peak fluctuations go, Arcutis Biotherapeutics' Prepaid Assets surged by 107.10% in 2021, and later decreased by 25.13% in 2022.
  • Over the past 5 years, Arcutis Biotherapeutics' Prepaid Assets (Yearly) stood at $6.8 million in 2020, then soared by 107.10% to $14.2 million in 2021, then dropped by 25.13% to $10.6 million in 2022, then spiked by 76.27% to $18.7 million in 2023, then increased by 5.09% to $19.7 million in 2024.